SCIENTIFIC PROGRAMME- AGOICON-2011 DAY 1 (9/12/2011-Friday) Kushabhadra Campus (Campus-5) KIIT University
|
|
- Stephen Rich
- 5 years ago
- Views:
Transcription
1 SCIENTIFIC PROGRAMME- AGOICON-2011 DAY 1 (9/12/2011-Friday) Kushabhadra Campus (Campus-5) KIIT University 8am onwards Registration HALL -A 8.30am-4.00pm 9 am 9.15 am : Pelvic Anatomy Amita Maheshwari 1. Live Gyn Onco Surgery Operative work-shop International Faculties Ronald Zweemer Netherland National Faculties - U D Bafna, R Kerkar Introduction: K. Uma Chairpersons: 8.30am-12.30pm pm-3.00pm 1. S P Somasekhar 1. Amal Kataki 2. Raksha Arora 2. S.B.L.Shrivastava 3. Pariseema Dave 3. R.L.Manjunath OT Coordinator OT-1 OT-2 1. Shilpa Patel 1. S.Padma 2. Yogesh Kulkarni 2. Sabhyata Gupta 3. Usha Rani Poli 3. Rahul R Choudhury 4.00pm -5.00pm Chairperson: Rama Joshi, Rupinder Sekhon, Indukala Robotic world Robotic video - S P Somasekhar Robotic surgeries in Gyn. malignancy J.Brown Robotics in Indian scenario Sabhyata Gupta 5.30pm 6.15 pm - AGOI oration Speaker - M Hakkama
2 -Cervical Cancer Control in developing world- At the end of 21 st century? Chairpersons - Kasturilal, Veena Jain, K. Uma. 6.30pm -Inauguration- Krishna Hall -Krishna Campus (Campus -7) - Followed by Reception committee dinner at venue HALL -B 9.00am-1.00PM- Work-shop on Preventive Oncology and Colposcopy 9.00 am noon 1. Cervical Cancer Prevention strategy 9.00am-10.00am Co-ordinator: Biswajit Das A. Introduction: Chairperson 1. Tushar Kar 2. Rahul Roy Choudhury 3. Santosh Behera 1. Principles of colposcopy Partha Basu 2. Detection of cervical neoplasia through colposcopy Usha Bohra 3. HPV as primary screening modality current perspectives Asha Jain 10.00am-11.00am B. Live demonstration-colposcopy, LEEP, Cryotherapy Chairperson & moderator: Dr SK Das Faculty Neerja Bhatla, Vijay Zutshi, 11.00am-12.00noon C. Panel discussion HPV vaccine frequently asked question. Moderator. Dr. Veena Jain Panelists: Uma Singh, Tushar Kar, Harsad Parsansis, Shilpa Patel, Pramila Jena, Shalini Rajaram, Sasmita Swain, Neerja Bhatla 12.00noon-1.00pm Evolution of strategies for Prevention of Cancer Cervix: Current Concepts Chairpersons: M.Hakama, Rani Reddy, S B L Srivastava HPV DNA test vs other modalities in Indian perspective -N.Bhatla 2. Care HPV- Indian Perspective -Usha Rani Poli 3. HPV Vaccine in developing world- Indian scenario - Partha Basu 2
3 1.00pm-2.00pm: Lunch Break 2.00pm -3.30pm Video Session 10x6 min Chairpersons: 1.Sean Dowdy, 2. H B Tongaonkar 3. K J Maula 1. Sub Diaphragmatic stripping - Amita Maheswari 2. Para Aortic Lymphadenectomy - S P Somasekhar 3. Systematic staging laparatomy - Rama Joshi 4. Bowel Resection & Splenectomy U D Bafna 5. Flap Surgeries in Carcinoma Vulva S K Giri 3.30pm-4.30pm Y-GOG programme Introduction Y GOG: K. Uma, Chairpersons: 1. Neerja Bhatla 2. R Ranade, 3. R L Manjunath Young Gynaecologic Oncologists and their contribution 1. Abhilasha Naraya -Small Cell Carcinoma of Cervix A Rare Entity 2. Kavitha Sukumar - Comparision of PAP smear, VIA and VILI as screening methods to detect CIN and cancer Cervix 3. MINI C.H. - PAP smear abnormalities in hospital patients 4. Shobha.K, - Study of stage I epithelial ovarian cancer- KMIO PERSPECTIVE 5. Niharika Dhiman - Endometrial Carcinoma: Where do we Stand? - Review of Clinicopathological Profile Over A Decade 4.30pm-5.30pm Preliminary written exam for oncoquiz for participants < 40 yrs - Manoranjan Mohapatra 3
4 Hall-C- Conference hall 9.00am-11.00am AGOI Tumour Registry Chair person - Matti Hakama, Experts: J Brown, Sean Dowdy, David Millan, KMIIO, TMH, AHRCC, Bangaladesh, GCRI, CNCI and others Hall Co-ordinators/ Raporteurs : Asha Jain, Jita Parija, Janmejay Mohapatra 11.00am -1.00pm AGOI Consensus meet pm Lunch break 4.30pm-5.30pm: EC meeting DAY 2 (10/12/2011- Saturday) Krishna Campus- (Campus-7), KIIT University 8a.m onwards- Registration Hall A Session- I Free communication-(fc) 8.00am- 9.00am - Cervical Malignancy Hall coordinators: Sujata Swain, Narahari Agasti, Rajani Dube Chairperson: Sushanta Mohapatra. J Parija, Sujit Behera 1. Shilpa Kava - Evaluation of P16INK4A as a biomarker in cervical intraepithelial neoplasia 4
5 2. D. N Sharma - Postoperative Radiotherapy Following I nadvertent Simple Hysterectomy versus Radical Hysterectomy for Cervical Carcinoma 3. P. Akila -Prevalence of CIN in HIV +ve women 4. Begum Rokeya Anwar - Knowledge, Attitude and Perception of Health Professionals regarding Cancer Cervix And it,s Screening In A Cancer Hospital 5. Lucy Pattanayak - Distant metastases in carcinoma of the uterine cervix. 6. Manoj Tangri - Diagnostic performance of contrast enhanced FDG-PET/CT in the assessment of lymph node in Operable cervical cancer. Hall- Krishna Session -II 9.00 am am- Plenary PREVENTIVE ONCOLOGY: - 18x2 min Chairpersons : 1. Michael Bookman, 2.Elizabeth Vellikad, 3 S. Chhabra, a. Familial Cancer Syndromes Ways to Prevent - R Zweemer b. Ovarian Cancer Screening - Veena Jain c. Fertility Issues in Gyn. Malignancy - S K Das 10.00am am Unresolved Issues Session -III 5 18x3 min Chairpersons: R.Zweemer, B.K Mohanty, J K Singh 1. Systematic Lymphadenectomy in Endometrial Cancer- worth doing - S.Dowdy 2. Role of Robotics in Gynecological Oncology services J.Brown 3. Intraperitoneal Chemotherapy in Ovarian Cancer M.Bookman
6 Session- IV am to Noon 12+3 Contemporary issues- Chairpersons: 1. J K Singh, 2. S N senapati, 3. Shahana Pervin 1. Prognostic variables in endometrial carcinoma - Amal kataki 2. CCRT in Cancer Cervix- -Ashutosh Gupta 3. Intraperitoneal Chemotherapy using Veress needle - R L manjunath 4. Bladder dysfunction after radical hyst.- ways to prevent - S Chhabra noon-1.00pm Newer trends in Diagnostics Session- V 12+5min Chairpersons: J.Brown, Uma Singh, K. C. Mohapatra 1. Role of Imaging in Gyn malignancy R Zweemer 2. Role of Sentinel node in Gyn onco service D K Vijay Kumar 3. HP Reporting & IHC in the management of Gyn Cancer D.Milan 4. Biomarkers in Cancer Cervix - Shalini Rajaram 1pm to 2pm- LUNCH Session- VI 2. 00pm-3.00 pm: Panel Discussion on GTD Moderator: Manas Biswas Experts: E. Vallikad, S.Habeebullah, S Padma, Vijay Zutshi, R.Arora, Dipti Samanta, Pralhad Kushtagi, Swopna Puri, David Millan Session- VII 3.00pm pm: Tumour board- Case discussion Moderator: R R Choudhury Experts: Sean Dowdy, Gauri Gandhi, Y. Kulkarni, SN Senapati, M. Bookman, Hemant tongaonkar Case presentation KMIO, AHRCC, TMH, 6
7 Session VIII pm: Prevention and management of Complication in Gyn Onco Surgery 15+5min Chairpersons : 1.. Sean Dowdy 2. Ashok Behera, 3. R. Kerkar, 1. Urological complications - H B Tongaonkar 2. Vascular Complications - Abraham Peedicaiyl 3. G I Complications - U D Bafna PM: AGOI GBM [to all AGOI members only] 7.00 Pm -Onwards: Banquet Dinner & Odisha Cultural Program POSTER SESSION-9.00am-1.00pm Time and space will be intimated on arrival 1.Tejal Kishor Gorasia - Phase II study of intraperitoneal chemotherapy in inoperable epithelial ovarian and primary peritoneal cancers. 2 Sanjukta Padhi - Rhabdomyosarcoma of the uterine cervix: A rare case report. 4. Biswaranjan Routray -A comparative study on radiation therapy Vs radiation therapy with concurrent chemotherapy in treating patients with high risk early stage cervical cancer after radical hysterectomy 7
8 5. Anupama R: -A Seven Year Profile of Carcinoma Endometrium from single institution of Kerala 6. Michelle Antony - Second Cancer after Carcinoma of the Cervix 7 Ashok Kumar Padhy -Inappropriate Hysterectomy in premalignant & malignant conditions of Cervix:10 yrs study at AHRCC 8 Sanjukta Padhi - Incidence of anaemia in cancer cervix. 9. Indira Palo - Arrhenoblastom:A rare Ovarian Tumour 10. Anupama R - Retrospective study of Carcinosarcoma of Uterus at Amrita Institute of Medical Sciences Niharika Dhiman -Early detection of ovarian cancer- It whispers, so listen am Hall- B Session I Free communication (FC) - Miscellaneous Hall coordinators: 1. Pradeep Panigrahi, 2. Babita Panda, 3. Sarika Avasti Chairpersons : Pratima Pattanaik, Amita Maheswari, A.Jain, 1. Khoorsheed Jahan Maula- Is Endometrial Cancer been diagnosed late? 2. Ashok Kumar Padhy -Endometrial Cancer:5 year experience at AHRCC, Cuttack 8
9 3. Anupama R -Recurrence pattern in Endometrial Cancer Experience from Amrita Institute of Medical Sciences 4. N R Mandal -Management of Vulval malignancy in Thakurpukur Cancer Hospital, Kolkata: a retrospective analysis of cases from the year 2000 to Savita Rani Singhal -Cancer Load In A Tertiary Care Referral Centre 6. Manas Ranjan Dandapat - Postmenopausal bleeding in elderly women am Symposium ca ovary Hall-Kavery Session-II 9 18 x 3min Chairpersons: 1. R Kerkar, 2. Santosh Behera, 3. Vijay Kumar- Vizag 1. Contralateral lymphadenectomy in unilateral epithelial ovarian cancer. - Pariseema Dave 2. Bio markers in ovarian malignancy - P L Dhand 3. MIS in cancer ovary - S. P. Somasekhar Session -III am Improving gyneac onco practice Chairpersons: 1. R L Manjunath, 2. Veena Jain, 3. Asma Rana 1. Diagnostic delay in gyn. Malignancies. -SBL Srivastava
10 2. Training & credentialing in gyn oncology -Partha Basu 3. Prognostic implications of grade of LVSI in epithelial ovarian ca. -David Millan noon Session IV Surgeon s Corner Chairpersons: 1. K S panda, 2.Satish Jain, 3. Savyata Gupta 1. Perioperative thromboprophylaxis -Bharati Mishra 2. Preoperative bowel preparation- is it necessary? -Elizabeth Vallikad 3. CSS in Endometrial Carcinoma- The pitfalls - Harsad Parsansis 12noon-1.00pm Session -V Vulva- The disputed area 12 min + 3 Chairpersons 1. S. Habeebullah 2. Pulak Roy 3.Krishna Dahiya 1. Surgical Anatomy of Vulva & Groin - Ajay Punpale 2. Precancerous lesions of vulva. -Savita Singhal 3. Localising lesions to decide management. -Vijay Zutshi 4. Radiation therapy in Vulval Cancer- pros and Cons - J.K Singh pm lunch pm Session -VI Capsule session 10
11 Chairpersons: 1. Ashok Behera 2. Savita Shingal 3. Ranu Patni 1. Malignancy in dermoid cyst - Arup Majhi 2. Endometrial stromal sarcoma - Gauri Gandhi 3. Robotics in Gynec Cancer (Video Talk) -Rupinder Sekhon 4. Dilemma in managing sex cord stromal tumours Rahul Roy choudhury 5. RMI - Prahlad Kushtagi PM Miscellaneous Session -VI 12 +3mts Chairpersons 1. Prahlad Kushtagi 2.V.K Ahuja 3.K B Subudhi 1. Minimizing lymphedema after surgery for cancer cervix. - Ranu Patni 2. Radical Trachelectomy the present status -Veena Agrawal 3. Treatment dilemma in locally advanced Ca Cx - Rita Rani 4. Borderline ovarian tumours dilemma in diagnosis & management - Indukala Session -VIII 4.00pm-5.00pm Panel Discussion Managing emergencies in Gynaecologic Oncology practice Moderator- D K. Vijay kumar Experts - Veena Agrawal, Krishna Dahiya, H. B. Tongaonkar, P K Das, Sarita Kothari, Prasant Nyati, Swapna Puri DAY -3 (11/12/2011- Sunday) Krishna Campus- (Campus-7), KIIT University 8am onwards Registration- Hall-A 11
12 Session -I 8.00am- 9.00am Free communication (FC) Coordinators Basanta pati, Shibananda Nayak, Asima Das Chairpersons: J. J. Mallick, Shilpa Patel, Yogesh Kulkarni Ovarian Cancer 1. Krishna Dahiya - Clinicopathological and prognostic characteristics of ovarian tumors in a tertiary care centre 2. Susri Ray Choudhuri (Guha) - Increased Activity and expression of Matrix Metalloproteinase(MMP)-9 & 13 in Epithelial Ovarian Cancer 3. Tejal Gorasia -A prospective comparison of perioperative morbidity in advanced epithelial ovarian cancer: Primary versus interval cytoreduction 4. Biswajeet Dash: -Adolescent Ovarian Tumour: Our Experience at AHRCC, Cuttack 5. Abhilasha Narayan -A Review of squamous cell carcinoma arising in mature cystic terratoma 6 Michelle Antony - Pattern of Recurrence and Treatment modalities in Granulosa Cell Tumor of the Ovary. 9am to am Recent Trends in Ovarian Cancer Hall- Krishna Session II min Chair persons: SKDas, Sujata Mohanty, Kasturilal 1. Translational research & Targeted therapy M.Bookman 2. Secondary cytoreductive surgery vs second line chemotherapy R Arora
13 3. Rare ovarian tumours J. Brown Session III AM Chairpersons: J J Mallick, Chhaya Sarodey, Pariseema Dave, Controversies in Gynaecological Cancers 12 4 min FIGO staging Facts & Fallacies - R. Ranade 2. Breaking the news -Gangadhar Sahoo 3. Quality of life issues in Gyn cancer survivors - PCMahapatra 4. Radical How radical a radical hysterectomy? - Amita Maheswari Session IV 1100 am to noon - Panel Discussion. Determining Adjuvant Therapy in early Gynaecological cancers Moderator: Rama Joshi, Experts: S.B.L.Shrivastava, Abraham Peedicaiyl, R.G.Ranade,, S. Senapati, J K Singh, Michael Bookman, Sean Dowdy Session V 12Noon -1PM Breast and gynaecologists Chairpersons : K. S. Panda, B. K. Mohanty Breast Cancer in India - K. S. Panda Early detection of Breast Cancer - D. Sarkar Panel Discussion: Moderator : K. S. Panda Experts: D Sarkar, B. K. Mohanty, S. P. Somasekhar, G. S. Biswas, Ranajit Kar, S. P. Pattnaik, N. Rout I.00PM Valedictory- Awards Y GOG & others 13
14 Lunch Hall-B Session-I am Free paper- CASE REPORT Coordinators S. Behera, S Khuntia, Lipi Pattanaik Chairpersons: J.K.singh, S. Habeebullah, Gangadhar Sahoo 1 Kavitha Sukumar - Unusual complication following Ileal Conduit 2. Sandhyasri Panda -Intersting case of Ca Cervix diagnosed incidentally on 23rd Post Op day while operated for Acute Abdomen 3. Sangeeta Pankaj -High grade pleomorphic sarcoma of ovary: a case report. 4. MINI C.H. -Transitional cell carcinoma of ovary 5. Gnana Sanker N - Going all out to treat a woman with terminally ill Choriocarcinoma 6. Shilpa Joshi - Malignant granulosa cell tumour. A case report from Ujjain am Kavery Hall Session II Endometrial Carcinoma- Management dilemma 14
15 Chairperson: David Milan, H B Tongaonkar, R. L Manjunath 1. Predictors of complications after surgery for endometrial cancer; - S Dowdy 2. High-risk Endometrial cancer- Ways to improve result - K Uma 3. Prognostic factors and Management decision - Harsad Paransis Session-III am Integrated Health care- End of life issue 15min Chairperson: 1. Sukdev Nayak, P. Devi, Rekha Das, 1. Assessment of Pain- a key to cancer Pain management -Sumita Mohanty 2. Intestinal obstruction in Ov cancer - Satish Jain 3. Improving Communication skills - Uma Singh 11.00am-12.00am Session- IV Video session: Laparoscopic World in Gynaec Onco Surgery Chair persons : Rajendra Kerkar, Shalini Rajaram, Manas Biswas Laporoscopic P-A dissection Extra peritoneal approach S.Dowdy Laparoscopic lymphadenectomy Intraperitoneal approach R.Zweemer Laparoscopic Inguinal Node Dissection - R.Sekhon noon-1.00pm Onco quiz Quiz master: Manoranjan Mohapatra Time keeper - Session- -V 15
16 Kindly send your itinerary details as soon as possible 16
Contents. Section I: Conventional Screening, Newer Screening Methods, HPV Carcinogenesis, Biomarkers and HPV Vaccination
Contents Section I: Conventional Screening, Newer Screening Methods, HPV Carcinogenesis, Biomarkers and HPV Vaccination 1. Cervical Cancer Screening in the Developing World...3 Rengaswamy Sankaranarayanan,
More informationHIV and AIDS Related Cancers DR GORDON AMBAYO UHS
HIV and AIDS Related Cancers DR GORDON AMBAYO UHS INTRODUCTION People with HIV/AIDS are at high risk for developing certain cancers, such as: Kaposi's sarcoma, non-hodgkin lymphoma, and cervical cancer.
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationGynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer
Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy
More informationGynecological Cancers in Primary Care
Gynecological Cancers in Primary Care Nora M. Lersch MSN CRNP AOCNP Division of Gynecological Oncology Objectives Identify the incidence of ovarian, cervical, vulvar and endometrial cancer Identify common
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationFOGSI GCPR Screening & Management of Cervical Precancerous Lesions and HPV Vaccination
FOGSI GCPR Screening & Management of Cervical Precancerous Lesions and HPV Vaccination FOGSI Good Clinical Practice Recommendation President In-charge: Dr Rishma Pai Vice President In-charge: Dr Ranjana
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationProposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram
Proposed All Wales Vulval Cancer Guidelines Dr Amanda Tristram Previous FIGO staging FIGO Stage Features TNM Ia Lesion confined to vulva with
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationAOGIN India E newsletter
AOGIN India E newsletter The quarterly newsletter of Asia Oceania research organization on Genital Infections and Neoplasia India Vol. 2, No. 3 September 2015 Founder President Dr. Neerja Bhatla Past President
More informationShift your surgical ambition to surgical action
Dates: February 1-3, 2018 3th International Meeting ENDO-Dubai : Updates in Minimal Invasive surgery in Gynecology Shift your surgical ambition to surgical action AGENDA AT A GLANCE Thursday, February
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationGynecological Cancers
Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer
THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT
More informationUPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER
UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review
More informationAOGIN India E newsletter
AOGIN India E newsletter The quarterly newsletter of Asia Oceania research organization on Genital Infections and Neoplasia India Vol. 3 No. 1 March 2016 Founder President Dr. Neerja Bhatla Past President
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationCervical Cancer 3/25/2019. Abnormal vaginal bleeding
Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms
More informationVaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationGYNECOLOGIC MALIGNANCIES: Ovarian Cancer
GYNECOLOGIC MALIGNANCIES: Ovarian Cancer KRISTEN STARBUCK, MD ROSWELL PARK CANCER INSTITUTE DEPARTMENT OF SURGERY DIVISION OF GYNECOLOGIC ONCOLOGY APRIL 19 TH, 2018 Objectives Basic Cancer Statistics Discuss
More informationFINAL SCIENTIFIC PROGRAMME
FINAL SCIENTIFIC PROGRAMME AGENDA Day 1 Speaker Chairpersons 8:30 AM 8:45 AM 8:45 AM 9:00 AM Intraperitoneal chemotherapytypes, techniques, tips Choice of drugs and carrier solutions for intraperitoneal
More informationFDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationMRI in Cervix and Endometrial Cancer
28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationThe Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD
The Role of Radiation in the Management of Gynecologic Cancers Scott Glaser, MD Nothing to disclose DISCLOSURE Outline The role of radiation in: Endometrial Cancer Adjuvant Medically inoperable Cervical
More informationGynecologic Oncology Overview Staging updates and Soap Box Issues
Gynecologic Oncology Overview Staging updates and Soap Box Issues Andrew. Green, M.D. Gynecologic Oncology Northeast Georgia Physician s Group Gainesville, GA 1 Overview 1) Review recent changes to FIGO/TNM
More informationARRO Case: Early-stage Endometrial Cancer
ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American
More informationChemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Find Studies About Studies Submit Studies Resources About Site Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer The safety and scientific validity of this study is
More informationGynecologic Cancer InterGroup Cervix Cancer Research Network. The SHAPE Trial
Gynecologic Cancer InterGroup Cervix Cancer Research Network The SHAPE Trial Comparing radical hysterectomy and pelvic node dissection against simple hysterectomy and pelvic node dissection in patients
More informationJanjira Petsuksiri, M.D
GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors
More information(WG Whitfield Growden, MD; DR Diane Redington, CRNP)
2795 Estates Drive Park City, UT 84060 TRANSCRIPT FOR VIDEO #4: D IAGNOSIS AND TREATMENT OF GYN CARCINOSARCOMA WITH DR. WHITFIELD GROWDEN Interview, Massachusetts General Hospital January 5, 2017 Produced
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION
More informationAudit Report Report of the 2010 Clinical Audit Data
Gynaecological Cancer Managed Clinical Network Audit Report Report of the Clinical Audit Data Nick Reed Consultant Clinical Oncologist MCN Clinical Lead (Joint) Nadeem Siddiqui Consultant Gynaecological
More information17 th ESO-ESMO Masterclass in clinical Oncology
17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated
More informationAOGIN India E newsletter
AOGIN India E newsletter The quarterly newsletter of Asia Oceania research organization on Genital Infections and Neoplasia India Vol. 2, No. 4 December 2015 Founder President Dr. Neerja Bhatla Past President
More informationRole of Surgery in Cervical Cancer & Research Questions
Role of Surgery in Cervical Cancer & Research Questions Arb-aroon Lertkhachonsuk, M.D., Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Role of surgery in cervical cancer
More informationClinical Pathological Conference. Malignant Melanoma of the Vulva
Clinical Pathological Conference Malignant Melanoma of the Vulva History F/48 Chinese Married Para 1 Presented in September 2004 Vulval mass for 2 months Associated with watery and blood stained discharge
More informationAlgorithms for management of Cervical cancer
Algithms f management of Cervical cancer Algithms f management of cervical cancer are based on existing protocols and guidelines within the ESGO comunity and prepared by ESGO Educational Committe as a
More informationGynaecological Oncology Unit Lead
Learning Outcomes: Gynaecological Oncology Unit Lead To develop knowledge and skills required by an individual to undertake the role as the Gynaecologial Oncology Unit Lead. Gynaecological Cancers Knowledge
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More informationSteamboat Springs, Colorado. January 15-18, 2016
Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status
More informationPLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018
PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:
More information73rd NATCON Scientific Programme Day-1 (January 05,2019) Registration (08.00AM AM)
73rd NATCON Scientific Programme Day-1 (January 05,2019) Registration (08.00AM-09.00 AM) Time Hall A Hall B Meetings 09.00-09.40 Chair: Dr. V.K. Arora, Dr. L.S. Chauhan, Dr. Radha Munje Oration1: 09.40-10.20
More informationMichael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center
Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy
More informationPrevention, Diagnosis and Treatment of Gynecologic Cancers
Prevention, Diagnosis and Treatment of Gynecologic Cancers Jubilee Brown MD and Pamela T. Soliman MD, MPH Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer
More informationGynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy
Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,
More informationBreast Cancer Research Workshop For Professionals INR 1000 For Students INR 500
Breast Cancer Research Workshop For Professionals INR 1000 For Students INR 500 TH 4 INDO-BRITISH ADVANCED MASTERCLASS IN ONCOPLASTIC BREAST SURGERY & BREAST CANCER SYMPOSIUM 2018 MMC ACCREDITED CME Combined
More informationGuideline for the Follow-up of Patients with Gynaecological Malignancies
Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated
More informationAudit Report Report of the 2012 Clinical Audit Data
Gynaecological Cancer Managed Clinical Network Audit Report Report of the 2012 Clinical Audit Data Nadeem Siddiqui Consultant Gynaecological Oncologist MCN Clinical Lead Kevin Campbell MCN Manager Julie
More informationNAACCR Webinar Series /7/17
COLLECTING CANCER DATA: UTERUS 2017 2018 NAACCR WEBINAR SERIES Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationRitu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University
Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States
More informationWhat Causes Cervical Cancer? Symptoms of Cervical Cancer
Cervical Health Awareness Month is a chance to raise awareness about how women can protect themselves from HPV (human papillomavirus) and cervical cancer. HPV is a very common infection that spreads through
More informationGynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.
Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationChallenges and successes with cervical cancer early detection and treatment in Kenya
Challenges and successes with cervical cancer early detection and treatment in Kenya Omenge Orangó MD Chair, Department of Reproductive Health and Divisional Head of Gynecologic Oncology, Moi University
More informationIn this Update, I report on the latest US
UPDATE Gynecologic cancer Jason D. Wright, MD Dr. Wright is Sol Goldman Associate Professor, Chief of Division of Gynecologic Oncology, Vice Chair of Academic Affairs, Department of Obstetrics and Gynecology,
More informationVagina. 1. Introduction. 1.1 General Information and Aetiology
Vagina 1. Introduction 1.1 General Information and Aetiology The vagina is part of internal female reproductive system. It is an elastic, muscular tube that connects the outside of the body to the cervix.
More informationInvitation from Chongqing, China.
Invitation from Chongqing, China. Dear Colleagues, You are cordially invited to join us for the AAGL Regional Meeting on Minimally Invasive Gynecology, in Chongqing, China, April 18 20. 2014. With the
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix
THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April
More informationJacqui Morgan March 6, 2019
Jacqui Morgan March 6, 2019 Case 1 25yo, G2P1 Here for WWE, no problems, healthy, needs refill on OCPs. Pap- Abnormal Glandular Cells-NOS Now What?? Case 1 Colposcopy What findings? Case 1 ECC Cervical
More informationReport from ESGO 16 October 2009, Belgrade, Serbia
Report from ESGO 16 October 2009, Belgrade, Serbia Interactive Index Prevention and early detection of gynaecological cancers Update on HPV vaccine efficacy and safety Treatment of cervical cancer Treatment
More informationARROCase: Locally Advanced Endometrial Cancer
ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal
More informationDEPARTMENT OF ONCOLOGY ELECTIVE
DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:
More informationTriage of Ovarian Masses. Andreas Obermair Brisbane
Triage of Ovarian Masses Andreas Obermair Brisbane Why Triage? In ovarian cancer, best outcomes for patients can be achieved when patients are treated in tertiary centres by a multidisciplinary team led
More informationOvarian cancer: clinical practice the Arabic perspective
Lead Group Log Ovarian cancer: clinical practice the Arabic perspective Experience of Hôtel-Dieu de France University Hospital (Beirut, LEBANON) in supraradical surgery for ovarian cancer David ATALLAH
More informationGynaecological Malignancies
Gynaecological Malignancies Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea Division of Pathology School of Medicine & Health Sciences Overview Genital tract tumors
More informationGynecologic Oncology Level: PGY-4
Gynecologic Oncology Level: PGY-4 Service: Oncology Length of Rotation: 4 months Supervision: PGY-4 Resident Oncology Faculty All resident activity is directly supervised by the attending physician assigned
More informationGynecologic Cancer. Cleveland Clinic Offers State-of-the-Art Cancer Care
Gynecologic Cancer Cleveland Clinic experts tailor treatment to their patients needs, taking into account the type of cancer, the age of the individual, the degree to which the cancer has spread and the
More informationsurgical staging g in early endometrial cancer
Risk adapted d approach to surgical staging g in early endometrial cancer Leon Massuger University Medical Centre St Radboud Nijmegen, The Netherlands Doing nodes Yes Yes Yes No No No 1957---------------------------
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationCOURSES ENDORSEMENT AND ACCREDITATION
COURSES ENDORSEMENT AND ACCREDITATION This course is organized in partnership with ESGO. This course meets the guidelines established in the "SAGES Framework for Post-Residency Surgical Education and Training"
More informationUniversity of Kentucky. Markey Cancer Center
University of Kentucky Markey Cancer Center Invasive Cancer of the Vagina and Urethra Fred Ueland, MD No matter what you accomplish in your life, the size of your funeral will still be determined by the
More informationLog Title: OBRES Gynecologic Case Log
Log Title: OBRES Gynecologic Case Log Hospital/Institution: (Lookup) Attending Physician (Lookup) Is Patient Pregnant? ( Y or N) MEDRECNO: (text) Date (encounter) (Date) Diagnosis DX GYN Acute Pelvic Pain
More informationPathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer
NICaN Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer Timed schedules to enable the proactive management of the patient from point of receipt of referral to first definitive treatment
More informationShared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1
Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Gynaecological sarcomas Version 1 Background This guidance is to provide direction for the management of patients with sarcomas
More informationDIPLOMA IN GYNECOLOGICAL ENDOSCOPY TRAINING (MIS 1 & MIS 2) 13TH 17TH March, 2019
DIPLOMA IN GYNECOLOGICAL ENDOSCOPY TRAINING (MIS 1 & MIS 2) 13TH 17TH March, 2019 Day 1-13th March, Wednesday 08:30 09:00 AM Registration and Attendance 09:00 AM 09:45 AM Anatomy is the mother and exposure
More informationPET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp
PET/CT in Gynaecological Cancers Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp Cervix cancer Outline of this talk Initial staging Treatment monitoring/guidance
More informationChapter 11 (Manual-10)
Chapter 11 (Manual10) The Monthly Remuneration received by each of its Officers and Employees including the System of compensation as provided in Regulations The ly remuneration to the officers and employees
More informationProgram Schedule. Update in Gynecology and Minimally Invasive Surgery 2018
Program Schedule Update in Gynecology and Minimally Invasive Surgery 2018 Wednesday, February 7, 2018 6:00 a.m. Registration & Breakfast with Exhibitors 6:55 a.m. Welcome Announcements SESSION: Practical
More informationRole and Techniques of Surgery in Carcinoma Cervix. Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh
Role and Techniques of Surgery in Carcinoma Cervix Dr Vanita Jain Additional Professor OBGYN PGIMER, Chandigarh Points for Discussion Pattern of spread Therapeutic options Types of surgical procedures
More informationDysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.
CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee
More informationIndex. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
More informationTHE BIRMINGHAM OVARIAN CANCER SURGERY MASTERCLASS
Pan-Birmingham Gynaecological Cancer Centre THE BIRMINGHAM OVARIAN CANCER SURGERY MASTERCLASS FOR GYNAECOLOGICAL ONCOLOGISTS AND TRAINEES Date 17-19 February 2014 Venue Pan-Birmingham Gynaecological Cancer
More informationCervical Cancer: 2018 FIGO Staging
Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford
More informationAtlas Of Gynecologic Surgical
Atlas Of Gynecologic Surgical 1 / 6 2 / 6 3 / 6 Atlas Of Gynecologic Surgical This atlas of surgical videos is enhanced with medically accurate 3D animation and aims to instruct surgeons in the surgical
More informationOppgave: MED5600_OPPGAVE04_V18_ORD
Side 23 av 63 Oppgave: MED5600_OPPGAVE04_V18_ORD Del 1: Sofie, 38 years, para1, comes to your office complaining about dyspareunia and spotting she has recently observed on several occasions, unrelated
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationFOGSI GCPR on Screening and Treatment of Preinvasive Lesions of Cervix & HPV vaccination
FOGSI GCPR on Screening and Treatment of Preinvasive Lesions of Cervix & HPV vaccination President In-charge: Dr Rishma Pai Vice President In-charge : Dr Ranjana Khanna Patrons: Dr CN Purandare Dr Alka
More informationOVARIAN CARCINOMA Immune Therapy. Antibodies to CA-125 (Ovarex) Vaccine therapy
OVARIAN CARCINOMA Immune Therapy Antibodies to CA-125 (Ovarex) Vaccine therapy OVARIAN CARCINOMA Targeted Therapy Bevacizumab (Avastin): GOG- 218 Anti-VEGF, angiogenesis inhibitor TLK 286 (Telcyta): Glutathione
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationUterus Malignancies /5/15
Collecting Cancer Data: Uterus 2014-2015 NAACCR Webinar Series February 5, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationGynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1
What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical
More informationPORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:
May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx
More informationProgram Schedule. 3 rd Annual Collaborative Symposium: Update in Minimally Invasive Gynecologic Surgery
Program Schedule 3 rd Annual Collaborative Symposium: Update in Minimally Invasive Gynecologic Surgery Thursday, February 5, 2015 6:45 a.m. Registration and Breakfast 7:25 a.m. Welcome / Announcements
More information